Benefits
DashboardNot registered yet? Get a free account.
Sign Up
VIDIT PHARMA SCIENCES PRIVATE LIMITED
Leave site?
You're about to leave our website and go to an external link. Are you sure?
Vidit Pharma Sciences Private Limited, is an unlisted private company incorporated on 21 January, 2022. It is classified as a private limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 15.00 lac and the total paid-up capital is INR 1.00 lac.
The current status of Vidit Pharma Sciences Private Limited is - Active.
Read more
Buy Dashboard using Credits
** All rupee values in INR crores. Based on March 2024 numbers.
8.9%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
No Reports Available
Tofler currently has no financial reports
for this company due to a lack of available
information. This may be because the company
is dormant or closed (see company status)
or because it was formed only recently
(check the incorporation date) and financial data
is not yet available.
You can view basic information by scrolling through the page.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
Choose number of credits to buy
₹ 449 + GST
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
Locations
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Select Tags
Choose Location
People
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Jayant Hari Ranade | 00004814 | 3 years |
| Director | Shraddha Vinayak Dhamankar | 00553157 | 3 years |
Financial Highlights
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Margins
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets
Charges on assets
As per information available, the company has no registered charges.
Company Network
Expand
Delete
Collapse
See
details
Companies connected through Directors
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| ALIVA NATURAL SCIENCES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| BOMBAY BIOSYNTEX CHEMICALS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| CAFCO CONSULTANTS LIMITED |
Active
|
6.6 L | 1 | Maharashtra |
| BOMBAY BIO-RESEARCH CENTRE PRIVATE LIMITED |
Active
|
1.9 Cr | 2 | Maharashtra |
| NEXGEN HEALTHCARE PRIVATE LIMITED |
Active
|
1.6 Cr | 2 | Maharashtra |
| SMRUTHI ORGANICS LTD |
Active
|
11.4 Cr | 1 | Maharashtra |
| EXCELLA PENCILS LIMITED |
Active
|
15.0 L | 1 | Maharashtra |
| UMALA HEALTHCARE PRIVATE LIMITED |
Active
|
19.0 L | 2 | Maharashtra |
| CAMART FINANCE LIMITED |
Active
|
10.0 L | 1 | Maharashtra |
| SYMMETRIX BIOTECH PRIVATE LIMITED |
Active
|
49.5 Cr | 2 | Maharashtra |
| SANGAM LABORATORIES LIMITED |
Amalgamated
|
2.8 Cr | 1 | Maharashtra |
| NLI HEALTHCARE (INDIA) PRIVATE LIMITED |
Active
|
10.0 L | 2 | Maharashtra |
| NOSTRUM TECHNOLOGIES PRIVATE LIMITED |
Active
|
20.8 Cr | 2 | Maharashtra |
| CHEMOLUTIONS CHEMICALS LIMITED |
Active
|
6.8 Cr | 1 | Maharashtra |
| VIBHA AGENCIES PRIVATE LIMITED |
Active
|
1.2 L | 1 | Maharashtra |
| MK FALCON AGROTECH PRIVATE LIMITED |
Active
|
11.8 Cr | 1 | Maharashtra |
| SAJR CHEMICALS PRIVATE LIMITED |
Under Process of Striking Off
|
27,000.0 | 1 | Maharashtra |
| THURS ORGANICS PRIVATE LIMITED |
Active
|
35.0 L | 1 | Maharashtra |
| ENEM NOSTRUM REMEDIES PRIVATE LIMITED |
Active
|
2.4 Cr | 1 | Maharashtra |
Tofler Score
Risk
Severe Risk
- No risks identified
Moderate Risk
- No risks identified
Low Risk
- No risks identified
About Tofler Score
Read more
Registered Details
CIN
U73200MH2022PTC375308PAN
-Incorporation
2022, 3.4 yearsCompany Email
info@viditpharma.comPaid up Capital
₹ 1.0 LAuthorised Capital
₹ 15.0 LAGM
N.A.Type
FAQ - VIDIT PHARMA SCIENCES PRIVATE LIMITED
What is the incorporation date of VIDIT PHARMA SCIENCES PRIVATE LIMITED?
The incorporation date of VIDIT PHARMA SCIENCES PRIVATE LIMITED is 21 January, 2022
What is the authorized share capital of VIDIT PHARMA SCIENCES PRIVATE LIMITED?
The authorized share capital of VIDIT PHARMA SCIENCES PRIVATE LIMITED is INR ₹ 15.0 L.
What is the paid-up capital of VIDIT PHARMA SCIENCES PRIVATE LIMITED?
The paid-up capital of VIDIT PHARMA SCIENCES PRIVATE LIMITED is INR ₹ 1.0 L.
What is the registered address of VIDIT PHARMA SCIENCES PRIVATE LIMITED?
The registered address of VIDIT PHARMA SCIENCES PRIVATE LIMITED is Unit No 101, Gayatri Commercial Complex Behind Mittal Ind Estate,Marol Andheri Mumbai Mumbai City Maharashtra - 400059
What is the CIN number of VIDIT PHARMA SCIENCES PRIVATE LIMITED?
The CIN number of VIDIT PHARMA SCIENCES PRIVATE LIMITED is U73200MH2022PTC375308.
Smart Suggestions
- Top Security Companies In India
- Highest Tax Paying Companies
- Best Matrimonial Sites
- Top Seed Companies In India
- Fortune 500 Companies In India
- ITC Products List
- Hindustan Unilever Products List
- Top Fan Brands
- Top Indian Companies By Revenue
- How To Check Directors Of A Company
- Automobile Parts Manufacturing Companies In India
- Forging Companies In India
- List Of Government Companies
- Road Construction Companies
- Top Engineering Companies
- Largets Banks By Market Cap
- Eyewear Companies In India
- Top Petrochemical Companies
- Manufacturing Companies In Coimbatore
- Medical Equipment Manufacturing Companies
- Top Companies In Odisha
- Financial Companies In India
- Top Mining Companies
- Top 10 Plastic Companies
- Leather Manufacturing Companies
